Tourmaline Bio, Inc.
TRMLDelisted Oct 28, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827506
Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.
Holders of 5% or more of TRML
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tourmaline Bio, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 13G/A | 9.95%2.56M shares | – | Nov 14, 20242 filings | Aug 14, 2025 | SEC |
| QVT Financial LP | 13G/A | 8.39%2.15M shares | +2.65 ppfrom 5.74% | May 15, 20252 filings | Aug 14, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 5.50%1.41M shares | – | Oct 22, 20243 filings | Oct 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
40 Schedule 13D and 13G filings on Tourmaline Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20254:19 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 0.00%0 shares | –Below 5% | Sep 30, 2025 | SEC |
| Oct 17, 20256:24 PM ET | BlackRock, Inc. | 13G/A | 5.50%1.41M shares | – | Sep 30, 2025 | SEC |
| Aug 14, 20254:00 PM ET | QVT Financial LP | 13G/A | 8.39%2.15M shares | +2.65 ppfrom 5.74% | Jun 30, 2025 | SEC |
| Aug 14, 20257:04 AM ET | Avoro Capital Advisors LLCand 1 other | 13G/A | 9.95%2.56M shares | – | Jun 30, 2025 | SEC |
| May 15, 20254:22 PM ET | QVT Financial LP | 13G | 5.74%1.47M shares | New | Mar 31, 2025 | SEC |
| Feb 14, 20255:09 PM ET | Blue Owl Capital Holdings LP | 13G/A | 4.20%1.08M shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Blue Owl Capital Holdings LP | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Viking Global Investors LPSuperinvestorViking Global Investors | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Avoro Capital Advisors LLC | 13GOld format | – | New | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Oct 22, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| Jun 3, 2024 | Ra Capital Management, L.P. | 13GOld format | – | – | – | SEC |
| Mar 15, 2024 | Pfizer Inc | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Blue Owl Capital Holdings LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Hydra LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Blackstone Holdings II L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | TCG Crossover GP I, LLC | 13GOld format | – | New | – | SEC |
| Feb 7, 2024 | BML Investment Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 6, 2023 | Hydra LLC | 13GOld format | – | New | – | SEC |
| Oct 30, 2023 | Longitude Capital Partners III, LLC | 13D/AOld format | – | – | – | SEC |
| Oct 30, 2023 | Qiming U.S. Healthcare GP II, LLC | 13D/AOld format | – | – | – | SEC |
| Oct 27, 2023 | Deep Track Capital, LP | 13GOld format | – | New | – | SEC |
| Oct 27, 2023 | Pfizer Inc | 13GOld format | – | New | – | SEC |
| Jul 6, 2023 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Apr 27, 2023 | BML Investment Partners, L.P. | 13GOld format | – | – | – | SEC |
| Apr 27, 2023 | BML Investment Partners, L.P. | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Aug 9, 20224:02 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 28, 2022 | Qiming U.S. Healthcare GP II, LLC | 13DOld format | – | New | – | SEC |
| Feb 14, 2022 | Viking Global Investors LPSuperinvestorViking Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Blackstone Holdings II L.P. | 13GOld format | – | New | – | SEC |
| Feb 4, 20224:12 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| May 21, 2021 | Longitude Capital Partners III, LLC | 13DOld format | – | New | – | SEC |
| May 21, 2021 | Citadel Advisors LLC | 13GOld format | – | New | – | SEC |
| May 17, 2021 | Viking Global Investors LPSuperinvestorViking Global Investors | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
4 notices from officers, directors and other affiliates planning to sell Tourmaline Bio, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jul 5, 20235:10 PM ET | Requadt ScottFormer Officer and Director | 11.8K | $36.3K | Jul 5, 2023 | Fidelity Brokerage Services LLC | SEC |
| Jul 5, 20234:52 PM ET | Fenton Mary KayOfficer | 12.9K | $39.9K | Jul 5, 2023 | Fidelity Brokerage Services LLC | SEC |
| Jun 1, 20234:21 PM ET | Suzanne IldstadDirector | 250.0K | $662.5K | Jun 1, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 21, 20234:32 PM ET | Suzanne IldstadOfficer | 10.1K | $24.0K | Apr 21, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |